Gritstone Oncology Inc

Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Gritstone Oncology reports strong financials and promising advancements in immunotherapy

Gritstone Oncology Inc showcases financial stability, progress in cancer immunotherapy, and advancements in infectious disease programs. Challenges include data requirements for ongoing studies, while opportunities lie in upcoming data presentations and exploring novel vaccine concepts.

Gritstone Oncology excels in Q1 with promising GRANITE program and samRNA advancements

Gritstone Oncology's Q1 2023 earnings call highlighted strong financials, progress in the GRANITE program, and advancements in the samRNA platform. Challenges include endpoint selection for Phase 3 study and managing pseudo progressors. Opportunities lie in combining immunotherapies for KRAS mutations and exploring adjuvant settings.

Gritstone Oncology reports positive Q1 results and eyes market expansion

Gritstone Oncology's Q1 2024 performance showcased positive outcomes in the GRANITE program and financial stability through strategic funding.
The company's strengths lie in promising immune responses, encouraging PFS data, and a proactive approach to clinical program advancement.
Challenges include data gaps in patient groups and uncertainties around future consortium data, while opportunities abound in market expansion and upcoming data releases.
Overall, Gritstone Oncology's focus on innovative cancer vaccine programs and financial prudence positions them well for future growth and clinical success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

LOS ANGELES, CA / ACCESSWIRE / July 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gritstone bio, Inc. ("Gritstone" or "the Company") (NASDAQ:GRTS) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 9, 2023 and February 29, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before August 6, 2024.

The Schall Law Firm Offers Guidance To Investors To Spearhead The Securities Fraud Legal Action Against Gritstone Bio Inc

NEW YORK, NY / ACCESSWIRE / July 19, 2024 / If you suffered a loss on your Gritstone bio, Inc. (NASDAQ:GRTS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gritstone-lawsuit-submission-form?prid=91464&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Notifies Gritstone bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – GRTS

NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gritstone bio, Inc. (NASDAQ: GRTS) between March 9, 2023 and February 29, 2024, both dates inclusive (the “Class Period”), of the important August 6, 2024 lead plaintiff deadline.

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GRTS

LOS ANGELES, CA / ACCESSWIRE / July 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gritstone bio, Inc. ("Gritstone" or "the Company") (NASDAQ:GRTS) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 9, 2023 and February 29, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before August 6, 2024.

The Schall Law Firm Provides Direction To Investors To Lead The Securities Fraud Lawsuit Against Gritstone Bio Inc

NEW YORK, NY / ACCESSWIRE / July 18, 2024 / If you suffered a loss on your Gritstone bio, Inc. (NASDAQ:GRTS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gritstone-lawsuit-submission-form?prid=91274&wire=1 or contact Joseph E. Levi, Esq.

Shareholders that Lost Money on Gritstone bio, Inc.(GRTS) Should Contact Levi & Korsinsky About Pending Class Action - GRTS

NEW YORK, NY / ACCESSWIRE / July 17, 2024 / If you suffered a loss on your Gritstone bio, Inc. (NASDAQ:GRTS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gritstone-lawsuit-submission-form?prid=91098&wire=1 or contact Joseph E. Levi, Esq.

Gritstone bio, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – GRTS

LOS ANGELES, CA / ACCESSWIRE /July 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gritstone bio, Inc. ("Gritstone" or "the Company") (NASDAQ:GRTS) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 9, 2023 and February 29, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before August 6, 2024.

Investors Receive Guidance From The Schall Law Firm To Spearhead The Securities Fraud Legal Battle Against Gritstone Bio Inc

NEW YORK , July 17, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Gritstone bio, Inc. (NASDAQ: GRTS). Shareholders who purchased shares of GRTS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

The Gross Law Firm Notifies Shareholders of Gritstone bio, Inc.(GRTS) of a Class Action Lawsuit and an Upcoming Deadline

NEW YORK, NY / ACCESSWIRE / July 17, 2024 / If you suffered a loss on your Gritstone bio, Inc. (NASDAQ:GRTS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gritstone-lawsuit-submission-form?prid=90987&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Notifies Shareholders of Gritstone bio, Inc. (GRTS) of a Class Action Lawsuit and an Upcoming Deadline

NEW YORK, NY / ACCESSWIRE / July 17, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Gritstone bio, Inc. ("Gritstone" or "the Company") (NASDAQ:GRTS) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Gritstone securities between March 9, 2023, and February 29, 2024, inclusive (the "Class Period").

GRTS SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Gritstone bio, Inc. Investors to Join the Class Action Lawsuit!

LOS ANGELES, CA / ACCESSWIRE / July 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gritstone bio, Inc. ("Gritstone" or "the Company") (NASDAQ:GRTS) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 9, 2023 and February 29, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before August 6, 2024.

Investors Are Provided Support By The Schall Law Firm To Spearhead The Securities Fraud Legal Case Against Gritstone Bio Inc

NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gritstone bio, Inc. (NASDAQ: GRTS) between March 9, 2023 and February 29, 2024, both dates inclusive (the “Class Period”), of the important August 6, 2024 lead plaintiff deadline.

ROSEN, A LONGSTANDING LAW FIRM, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GRTS

NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Gritstone bio, Inc. (NASDAQ: GRTS).

Investors in Gritstone bio, Inc. Should Contact The Gross Law Firm Before August 6, 2024 to Discuss Your Rights – GRTS

LOS ANGELES, CA / ACCESSWIRE / July 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gritstone bio, Inc. ("Gritstone" or "the Company") (NASDAQ:GRTS) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 9, 2023 and February 29, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before August 6, 2024.

Investors Receive Backing From The Schall Law Firm To Lead The Securities Fraud Legal Case Against Gritstone Bio Inc

LOS ANGELES, CA / ACCESSWIRE / July 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gritstone bio, Inc. ("Gritstone" or "the Company") (NASDAQ:GRTS) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 9, 2023 and February 29, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before August 6, 2024.

The Schall Law Firm Assists Investors In Leading The Securities Fraud Legal Case Against Gritstone Bio Inc

NEW YORK, NY / ACCESSWIRE / July 11, 2024 / If you suffered a loss on your Gritstone bio, Inc. (NASDAQ:GRTS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gritstone-lawsuit-submission-form?prid=90426&wire=1 or contact Joseph E. Levi, Esq.

Gritstone bio, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before August 6, 2024 to Discuss Your Rights – GRTS

NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gritstone bio, Inc. (NASDAQ: GRTS) between March 9, 2023 and February 29, 2024, both dates inclusive (the “Class Period”), of the important August 6, 2024 lead plaintiff deadline.

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GRTS

LOS ANGELES, CA / ACCESSWIRE / July 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gritstone bio, Inc. ("Gritstone" or "the Company") (NASDAQ:GRTS) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 9, 2023 and February 29, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before August 6, 2024.

Investors Are Provided Support By The Schall Law Firm To Spearhead The Securities Fraud Legal Action Against Gritstone Bio Inc

NEW YORK, NY / ACCESSWIRE / July 10, 2024 / If you suffered a loss on your Gritstone bio, Inc. (NASDAQ:GRTS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gritstone-lawsuit-submission-form?prid=90238&wire=1 or contact Joseph E. Levi, Esq.

Class Action Filed Against Gritstone bio, Inc. (GRTS) Seeking Recovery for Investors – Contact Levi & Korsinsky

Investors can contact the law firm at no cost to learn more about recovering their losses

Gritstone bio, Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm

NEW YORK, NY / ACCESSWIRE / July 10, 2024 / If you suffered a loss on your Gritstone bio, Inc. (NASDAQ:GRTS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gritstone-lawsuit-submission-form?prid=90171&wire=1 or contact Joseph E. Levi, Esq.

Investors who lost money on Gritstone bio, Inc. (GRTS) should contact Levi & Korsinsky about pending Class Action - GRTS

LOS ANGELES, CA / ACCESSWIRE / July 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gritstone bio, Inc. ("Gritstone" or "the Company") (NASDAQ:GRTS) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 9, 2023 and February 29, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before August 6, 2024.

The Schall Law Firm Offers Assistance To Investors To Lead The Securities Fraud Lawsuit Against Gritstone Bio Inc

EMERYVILLE, Calif., July 10, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world's most potent vaccines, today announced that the Compensation Committee of the company's Board of Directors granted one employee nonqualified stock options to purchase an aggregate of 39,000 shares of its common stock with an exercise price of $0.57, which is equal to the closing price of Gritstone's common stock on July 3, 2024, the date of the grant. These stock options are part of an inducement material to the new employees becoming an employee of Gritstone, in accordance with Nasdaq Listing Rule 5635(c)(4).

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK, July 09, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Gritstone bio, Inc. (NASDAQ: GRTS).

Class Action Filed Against Gritstone bio, Inc. (GRTS) - August 6, 2024 Deadline to Join – Contact The Gross Law Firm

LOS ANGELES, CA / ACCESSWIRE / July 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gritstone bio, Inc. ("Gritstone" or "the Company") (NASDAQ:GRTS) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 9, 2023 and February 29, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before August 6, 2024.

News for Gritstone Oncology Inc Stock (GRTS)